Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

21 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Litigation -- 2nd Update

share with twitter share with LinkedIn share with facebook
share via e-mail
02/14/2020 | 10:35am EDT

By Jared S. Hopkins

An $18 billion settlement offer from three major drug wholesalers aimed at resolving litigation over their alleged role in the opioid crisis appears to have fallen apart, after more than 20 state attorneys general rejected it in a letter sent to the companies' law firms this week.

The letter, reviewed by The Wall Street Journal, shows that the drug industry hasn't won enough support from states to begin moving the sprawling litigation to a global resolution.

The dissenting states want the wholesalers to contribute between $22 billion and $32 billion, according to a person familiar with the matter.

The rejection is the latest setback in negotiations to resolve the nation's complex opioid-crisis litigation, which began several years ago. The majority of the lawsuits have been consolidated in federal court in Cleveland, though state attorneys general have largely pursued cases in their own state courts.

The parties have been holding talks since at least October, when The Wall Street Journal reported that the three distributors -- McKesson Corp., AmerisourceBergen Corp., and Cardinal Health Inc. -- were in talks to collectively pay $18 billion over 18 years. Johnson & Johnson was also involved in the discussions to contribute additional money, the Journal reported.

The letter was signed by attorneys general for 21 states as well as Puerto Rico and the District of Columbia and include some of the hardest hit by the opioid crisis, including Ohio and West Virginia.

AmeriSourceBergen said it remains committed to a "fair negotiated resolution" but will continue to defend itself in court and is preparing for upcoming trials. It said in a statement it was "disappointed to hear that some states do not currently understand the merits of the global settlement framework that the distributors have been discussing with the attorneys' general over the past many months."

McKesson said it is focused on "finalizing a global settlement structure that would serve as the best path forward to provide billions of dollars in immediate funding and relief to states and local communities." The company said it is committed to be part of a solution but is prepared to defend itself in litigation.

Cardinal Health didn't respond to a request for comment.

Ohio Attorney General Dave Yost said in an interview the letter shows the states "who are not willing to sign on" to the settlement. He said the wholesalers should pay their $18 billion in a shorter time period or provide more funding.

The letter is signed mostly by Democratic attorneys general, although there are some Republicans, including West Virginia's Patrick Morrissey and Florida's Ashley Moody.

"Each of you has expressed that your clients seek a settlement that is global," the letter reads. "It is our collective view that the most recently communicated offer is unlikely to achieve that goal. We invite you to discuss our specific issues more fully so that a global settlement may be reached."

States in support of the deal remain optimistic that a global resolution can be worked out, according to a person familiar with the negotiations. Talks for the deal have been lead by a bipartisan group of attorneys general from North Carolina, Texas, Pennsylvania and Tennessee. Those attorneys general didn't sign the letter.

Write to Jared S. Hopkins at jared.hopkins@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
AMERISOURCEBERGEN CORPORATION -2.57% 86.23 Delayed Quote.4.09%
CARDINAL HEALTH, INC. -0.48% 47.71 Delayed Quote.-5.22%
MCKESSON CORPORATION -1.63% 133.06 Delayed Quote.-3.80%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MCKESSON CORPORATION
04/01MCKESSON CORPORATION : - The US Oncology Network names renowned cancer researche..
AQ
03/23MCKESSON : Announces Bansi Nagji to Step Down as Executive Vice President, Chief..
BU
03/17MCKESSON CORP : Regulation FD Disclosure, Financial Statements and Exhibits (for..
AQ
03/17MCKESSON : Updates Fiscal 2020 Guidance Following Completion of Change Healthcar..
BU
03/13MCKESSON CORP : Entry into a Material Definitive Agreement, Regulation FD Disclo..
AQ
03/13MCKESSON CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,..
AQ
03/10MCKESSON : Completes Split-off of Its Interest in Change Healthcare
BU
03/10MCKESSON : Announces Preliminary Results of Exchange Offer
BU
03/06MCKESSON CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/05MCKESSON : Sets Final Exchange Ratio of 11.4086 for Exchange Offer
BU
More news
Financials (USD)
Sales 2020 228 B
EBIT 2020 3 777 M
Net income 2020 475 M
Debt 2020 4 780 M
Yield 2020 1,20%
P/E ratio 2020 51,5x
P/E ratio 2021 10,2x
EV / Sales2020 0,13x
EV / Sales2021 0,12x
Capitalization 23 952 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 162,76  $
Last Close Price 135,26  $
Spread / Highest target 45,6%
Spread / Average Target 20,3%
Spread / Lowest Target 3,50%
EPS Revisions
Managers
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Edward A. Mueller Chairman
Britt Vitalone Chief Financial Officer & Executive Vice President
Nancy Flores EVP, Chief Technology & Information Officer
M. Christine Jacobs Independent Director
Sector and Competitors